Acasti Pharma Inc (ACST)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Apr 23, 14:51
Acasti Pharma Market Cap: 25.94M for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 26.79M |
| April 19, 2024 | 26.98M |
| April 18, 2024 | 28.86M |
| April 17, 2024 | 29.98M |
| April 16, 2024 | 31.49M |
| April 15, 2024 | 31.58M |
| April 12, 2024 | 32.00M |
| April 11, 2024 | 31.96M |
| April 10, 2024 | 31.96M |
| April 09, 2024 | 31.96M |
| April 08, 2024 | 31.96M |
| April 05, 2024 | 31.96M |
| April 04, 2024 | 31.96M |
| April 03, 2024 | 31.77M |
| April 02, 2024 | 32.24M |
| April 01, 2024 | 32.43M |
| March 28, 2024 | 32.19M |
| March 27, 2024 | 31.96M |
| March 26, 2024 | 31.96M |
| March 25, 2024 | 32.05M |
| March 22, 2024 | 31.96M |
| March 21, 2024 | 31.96M |
| March 20, 2024 | 31.96M |
| March 19, 2024 | 31.96M |
| March 18, 2024 | 31.96M |
| Date | Value |
|---|---|
| March 15, 2024 | 31.77M |
| March 14, 2024 | 32.05M |
| March 13, 2024 | 31.96M |
| March 12, 2024 | 32.24M |
| March 11, 2024 | 31.49M |
| March 08, 2024 | 31.96M |
| March 07, 2024 | 31.96M |
| March 06, 2024 | 32.05M |
| March 05, 2024 | 32.00M |
| March 04, 2024 | 32.33M |
| March 01, 2024 | 32.29M |
| February 29, 2024 | 31.39M |
| February 28, 2024 | 31.96M |
| February 27, 2024 | 31.30M |
| February 26, 2024 | 31.68M |
| February 23, 2024 | 31.49M |
| February 22, 2024 | 31.63M |
| February 21, 2024 | 31.39M |
| February 20, 2024 | 29.23M |
| February 16, 2024 | 31.02M |
| February 15, 2024 | 28.76M |
| February 14, 2024 | 24.81M |
| February 13, 2024 | 22.75M |
| February 12, 2024 | 24.53M |
| February 09, 2024 | 23.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
13.18M
Minimum
Sep 22 2023
245.12M
Maximum
Dec 20 2019
63.61M
Average
47.17M
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 739.72M |
| Edesa Biotech Inc | 14.05M |
| Lexaria Bioscience Corp | 29.64M |
| Xenon Pharmaceuticals Inc | 3.126B |
| ESSA Pharma Inc | 289.76M |
Market Cap Related Metrics
| Price to Book Value | 0.4011 |
| Price | 2.76 |
| Earnings Yield | -165.9% |